Therapy Areas: AIDS & HIV
King-Devick technologies passes US FDA clearance for K-D Balance App
18 April 2018 - Assessment tools company King-Devick technologies inc reported on Tuesday the receipt of the 510(k) clearance from the US Food and Drug Administration (FDA) to market its new K-D Balan...
Roche wins US FDA clearance for cobas CT/NG on cobas 6800/8800 systems for detecting Chlamydia trachomatis & Neisseria gonorrhoeae
17 April 2018 - Pharmaceuticals company Roche (SIX:RO) (OTCQX:RHHBY) reported on Monday the receipt of US Food and Drug Administration (FDA) 510(k) clearance for cobas CT/NG for use on the cobas 6800/...
DotLab Endometriosis Test Shows Potential for Monitoring Disease Progression and Treatment Response
3 April 2018 - - San Francisco, California-based personalized medicine company DotLab has released results from a new study showing that its endometriosis test, which aids in diagnosing the disease, h...
Mylan to unveil Symfi triple combo once-daily HIV treatment in the US
29 March 2018 - Pharmaceutical company Mylan NV (NASDAQ:MYL) stated on Wednesday that it will introduce its third cost-saving US Food and Drug Administration (FDA) approved Symfi (efavirenz, lamivudin...
Mylan to launch Symfi Triple Combo in US
29 March 2018 - Mylan NV (NASDAQ: MYL), a global pharmaceutical company, is launching its Symfi Triple Combo, a third cost-saving HIV combination, in the United States, it was reported yesterday.The U...
CHMP Issues Janssen Positive Opinion for Juluca (dolutegravir/rilpivirine)
27 March 2018 - - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued Janssen Pharmaceutical Companies, a segment of US-based global healthcare compan...